Business Wire: Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes
Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes
WRIC: Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules
Hexagon’s interdisciplinary platform enables broad opportunities across multiple therapeutic areas; company initially focused on oncology and infectious diseases Tara Arvedson, Ph.D., former Executive ...
Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules
Hexagon has agreed to acquire Waygate Technologies from Baker Hughes in a $1.45 billion all-cash deal. Waygate generates $630M in revenue.
BOSTON--(BUSINESS WIRE)--Hexagon Technologies officially launches its Enterprise Business Monitoring software platform designed to give firms a pro-active and timely approach to capitalizing on ...
C&EN: Hexagon Bio gets $47 million to mine fungus genomes for new drugs
Hexagon Bio, a Menlo Park, California–based company trying to develop drugs from natural defense compounds secreted by fungi, has raised $47 million in series A financing. The funds will be used to ...
Hexagon Bio gets $47 million to mine fungus genomes for new drugs
- Proceeds to fund expansion of leading-edge, interdisciplinary drug discovery platform and advance a preclinical pipeline initially focused on oncology and infectious diseases - Funding led by ...
Seeking Alpha: Corteva, Hexagon Bio Form Multi-Million Dollar JV to Power Next-Generation of Nature Inspired Solutions
INDIANAPOLIS & MENLO PARK, Calif.--(BUSINESS WIRE)-- Corteva (CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover ...